- December 24, 2021
- Posted by: Stratford Team
- Category: Business
Check out what’s clicking on FoxBusiness.com.
The Food and Drug Administration (FDA) on Thursday authorized the use of Merck’s molnupiravir pill for treating COVID-19, the second such emergency use authorization in two days.
Who can take the Merck COVID-19 pill?
The molnupiravir pill is cleared for use by adults 18 and older who have tested positive for COVID-19 and are at high risk of being hospitalized or dying.
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck is seen in this undated handout photo obtained by Reuters May 17, 2021. (Merck & Co Inc/Handout via REUTERS)
The FDA on Wednesday authorized Pfizer’s paxlovin drug. Both pills may be taken orally at home, giving health care providers another tool to prevent severe disease amid a wave of omicron variant infections.
COVID-19 OMICRON VARIANT DISRUPTS TRAVEL PLANS
“As new variants of the virus continue to emerge, it is crucial to expand the…
